TRACK: Newsletter - Issue 03 - 11 May 2021



Issue 3   |  11 May 2021 


Study Overview
The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.


Participant Recruitment


Meet the Team


Progress Updates

To remain up to date on site status, visit;